Although there are no current studies exploring the expression of SphK specific isoforms in cancer patients, these initial in vitro studies in cancer cell lines, suggest that differences in SphK1 isoform expression may be relevant in anti-SphK/S1P/S1PR cancer based therapies. Here, SPHK1 is linked to cancer.